APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cobamamide Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cobamamide Drugs Industry Growth and Trends Forecast to 2032

Report ID 17397911012 January 202697 pages

Choose your research edition.

Industry ResearchCobamamide Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cobamamide Drugs Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Cobamamide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cobamamide Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cobamamide Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Cobamamide Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cobamamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cobamamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cobamamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cobamamide Drugs include Chongqing Yaoyou Pharmaceutical, Jiuquan Dadeli pharmaceutical, Jiangsu Jiuxu Pharmaceutical, North China Pharmaceutical Group, Hebei Zhitong Biopharmaceutical, Hainan Star Pharmaceutical, Haerbin Medisan and Sinopharm Group Rongsheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cobamamide Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cobamamide Drugs market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cobamamide Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cobamamide Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cobamamide Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cobamamide Drugs Market by Company

Chongqing Yaoyou Pharmaceutical

Jiuquan Dadeli pharmaceutical

Jiangsu Jiuxu Pharmaceutical

North China Pharmaceutical Group

Hebei Zhitong Biopharmaceutical

Hainan Star Pharmaceutical

Haerbin Medisan

Sinopharm Group Rongsheng Pharmaceutical

Cobamamide Drugs Segment by Type

Injection

Tablets

Cobamamide Drugs Segment by Application

Hospital

Drug Store

Other

Cobamamide Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobamamide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cobamamide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobamamide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cobamamide Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cobamamide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Tablets Table 3. Global Cobamamide Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cobamamide Drugs Sales by Type (2021-2026) & (Kg) Table 5. Global Cobamamide Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cobamamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cobamamide Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Cobamamide Drugs Price by Type (2021-2026) & (US$/g) Table 9. Global Cobamamide Drugs Sales by Type (2027-2032) & (Kg) Table 10. Global Cobamamide Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cobamamide Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cobamamide Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Cobamamide Drugs Price by Type (2027-2032) & (US$/g) Table 14. North America Cobamamide Drugs Sales by Type (2021-2026) & (Kg) Table 15. North America Cobamamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cobamamide Drugs Sales by Type (2021-2026) & (Kg) Table 17. Europe Cobamamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cobamamide Drugs Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Cobamamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cobamamide Drugs Sales by Type (2021-2026) & (Kg) Table 21. Latin America Cobamamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cobamamide Drugs Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Cobamamide Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Cobamamide Drugs Industry Trends Table 25. Cobamamide Drugs Industry Drivers Table 26. Cobamamide Drugs Industry Opportunities and Challenges Table 27. Cobamamide Drugs Industry Restraints Table 28. Global Cobamamide Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cobamamide Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Cobamamide Drugs Sales by Company (2021-2026) & (Kg) Table 31. Global Cobamamide Drugs Sales Share by Company (2021-2026) Table 32. Global Cobamamide Drugs Market Price by Company (2021-2026) & (US$/g) Table 33. Global Cobamamide Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cobamamide Drugs Major Company Production Sites and Headquarters Table 35. Global Cobamamide Drugs Company, Product Type & Application Table 36. Global Cobamamide Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cobamamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cobamamide Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cobamamide Drugs Sales by Region (2021-2026) & (Kg) Table 41. Global Cobamamide Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cobamamide Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cobamamide Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Cobamamide Drugs Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Cobamamide Drugs Sales by Region (2027-2032) & (Kg) Table 46. Global Cobamamide Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cobamamide Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cobamamide Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Cobamamide Drugs Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Cobamamide Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cobamamide Drugs Sales by Application (2021-2026) & (Kg) Table 52. Global Cobamamide Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cobamamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cobamamide Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Cobamamide Drugs Price by Application (2021-2026) & (US$/g) Table 56. Global Cobamamide Drugs Sales by Application (2027-2032) & (Kg) Table 57. Global Cobamamide Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cobamamide Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cobamamide Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Cobamamide Drugs Price by Application (2027-2032) & (US$/g) Table 61. North America Cobamamide Drugs Sales by Application (2021-2026) & (Kg) Table 62. North America Cobamamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cobamamide Drugs Sales by Application (2021-2026) & (Kg) Table 64. Europe Cobamamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cobamamide Drugs Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Cobamamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cobamamide Drugs Sales by Application (2021-2026) & (Kg) Table 68. Latin America Cobamamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cobamamide Drugs Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Cobamamide Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Chongqing Yaoyou Pharmaceutical Company Information Table 72. Chongqing Yaoyou Pharmaceutical Business Overview Table 73. Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Product Portfolio Table 75. Chongqing Yaoyou Pharmaceutical Recent Development Table 76. Jiuquan Dadeli pharmaceutical Company Information Table 77. Jiuquan Dadeli pharmaceutical Business Overview Table 78. Jiuquan Dadeli pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. Jiuquan Dadeli pharmaceutical Cobamamide Drugs Product Portfolio Table 80. Jiuquan Dadeli pharmaceutical Recent Development Table 81. Jiangsu Jiuxu Pharmaceutical Company Information Table 82. Jiangsu Jiuxu Pharmaceutical Business Overview Table 83. Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Product Portfolio Table 85. Jiangsu Jiuxu Pharmaceutical Recent Development Table 86. North China Pharmaceutical Group Company Information Table 87. North China Pharmaceutical Group Business Overview Table 88. North China Pharmaceutical Group Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. North China Pharmaceutical Group Cobamamide Drugs Product Portfolio Table 90. North China Pharmaceutical Group Recent Development Table 91. Hebei Zhitong Biopharmaceutical Company Information Table 92. Hebei Zhitong Biopharmaceutical Business Overview Table 93. Hebei Zhitong Biopharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 94. Hebei Zhitong Biopharmaceutical Cobamamide Drugs Product Portfolio Table 95. Hebei Zhitong Biopharmaceutical Recent Development Table 96. Hainan Star Pharmaceutical Company Information Table 97. Hainan Star Pharmaceutical Business Overview Table 98. Hainan Star Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 99. Hainan Star Pharmaceutical Cobamamide Drugs Product Portfolio Table 100. Hainan Star Pharmaceutical Recent Development Table 101. Haerbin Medisan Company Information Table 102. Haerbin Medisan Business Overview Table 103. Haerbin Medisan Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 104. Haerbin Medisan Cobamamide Drugs Product Portfolio Table 105. Haerbin Medisan Recent Development Table 106. Sinopharm Group Rongsheng Pharmaceutical Company Information Table 107. Sinopharm Group Rongsheng Pharmaceutical Business Overview Table 108. Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 109. Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Product Portfolio Table 110. Sinopharm Group Rongsheng Pharmaceutical Recent Development Table 111. North America Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 112. North America Cobamamide Drugs Sales by Country (2021-2026) & (Kg) Table 113. North America Cobamamide Drugs Sales Market Share by Country (2021-2026) Table 114. North America Cobamamide Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 115. North America Cobamamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. North America Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Cobamamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Cobamamide Drugs Market Share by Country (2021-2026) Table 119. North America Cobamamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Cobamamide Drugs Market Share Forecast by Country (2027-2032) Table 121. Europe Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 122. Europe Cobamamide Drugs Sales by Country (2021-2026) & (Kg) Table 123. Europe Cobamamide Drugs Sales Market Share by Country (2021-2026) Table 124. Europe Cobamamide Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 125. Europe Cobamamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Cobamamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Cobamamide Drugs Market Share by Country (2021-2026) Table 129. Europe Cobamamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Cobamamide Drugs Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Cobamamide Drugs Sales by Country (2021-2026) & (Kg) Table 133. Asia-Pacific Cobamamide Drugs Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Cobamamide Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 135. Asia-Pacific Cobamamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Cobamamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Cobamamide Drugs Market Share by Country (2021-2026) Table 139. Asia-Pacific Cobamamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Cobamamide Drugs Market Share Forecast by Country (2027-2032) Table 141. Latin America Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 142. Latin America Cobamamide Drugs Sales by Country (2021-2026) & (Kg) Table 143. Latin America Cobamamide Drugs Sales Market Share by Country (2021-2026) Table 144. Latin America Cobamamide Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 145. Latin America Cobamamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Cobamamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Cobamamide Drugs Market Share by Country (2021-2026) Table 149. Latin America Cobamamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Cobamamide Drugs Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Cobamamide Drugs Sales by Country (2021-2026) & (Kg) Table 153. Middle East and Africa Cobamamide Drugs Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Cobamamide Drugs Sales Forecast by Country (2027-2032) & (Kg) Table 155. Middle East and Africa Cobamamide Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Cobamamide Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Cobamamide Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Cobamamide Drugs Market Share by Country (2021-2026) Table 159. Middle East and Africa Cobamamide Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Cobamamide Drugs Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Cobamamide Drugs Distributors List Table 164. Cobamamide Drugs Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Cobamamide Drugs Image Figure 2. Global Cobamamide Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cobamamide Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Cobamamide Drugs Sales (2021-2032) & (Kg) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (Kg) Figure 7. Tablets Image Figure 8. Global Tablets Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Cobamamide Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cobamamide Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Cobamamide Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Cobamamide Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Cobamamide Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cobamamide Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cobamamide Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cobamamide Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cobamamide Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cobamamide Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cobamamide Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cobamamide Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cobamamide Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (Kg) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (Kg) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (Kg) Figure 29. Global Cobamamide Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cobamamide Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Cobamamide Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Cobamamide Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Cobamamide Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cobamamide Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cobamamide Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cobamamide Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cobamamide Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cobamamide Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cobamamide Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cobamamide Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Cobamamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 42. North America Cobamamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cobamamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cobamamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cobamamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 46. Europe Cobamamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cobamamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cobamamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cobamamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. Asia-Pacific Cobamamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cobamamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cobamamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cobamamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Latin America Cobamamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cobamamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cobamamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cobamamide Drugs Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Middle East and Africa Cobamamide Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cobamamide Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cobamamide Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cobamamide Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cobamamide Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablets
Applications
  • Hospital
  • Drug Store
  • Other
Companies covered
  • Chongqing Yaoyou Pharmaceutical
  • Jiuquan Dadeli pharmaceutical
  • Jiangsu Jiuxu Pharmaceutical
  • North China Pharmaceutical Group
  • Hebei Zhitong Biopharmaceutical
  • Hainan Star Pharmaceutical
  • Haerbin Medisan
  • Sinopharm Group Rongsheng Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cobamamide Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cobamamide Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cobamamide Drugs Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Tablets
  8. 1.4 Global Cobamamide Drugs Market Size by Type
  9. 1.4.1 Global Cobamamide Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cobamamide Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cobamamide Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cobamamide Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cobamamide Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cobamamide Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cobamamide Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cobamamide Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cobamamide Drugs Industry Trends
  2. 2.2 Cobamamide Drugs Industry Drivers
  3. 2.3 Cobamamide Drugs Industry Opportunities and Challenges
  4. 2.4 Cobamamide Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cobamamide Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Cobamamide Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Cobamamide Drugs Price (2021-2026)
  4. 3.4 Global Cobamamide Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cobamamide Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Cobamamide Drugs Company, Product Type & Application
  7. 3.7 Global Cobamamide Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cobamamide Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cobamamide Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cobamamide Drugs Tier 1, Tier 2, and Tier 3
4 Cobamamide Drugs Regional Status and Outlook
  1. 4.1 Global Cobamamide Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cobamamide Drugs Historic Market Size by Region
  3. 4.2.1 Global Cobamamide Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cobamamide Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cobamamide Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cobamamide Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Cobamamide Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cobamamide Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cobamamide Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cobamamide Drugs by Application
  1. 5.1 Cobamamide Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.1.3 Other
  5. 5.2 Global Cobamamide Drugs Market Size by Application
  6. 5.2.1 Global Cobamamide Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cobamamide Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cobamamide Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cobamamide Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cobamamide Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cobamamide Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cobamamide Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cobamamide Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Yaoyou Pharmaceutical
  2. 6.1.1 Chongqing Yaoyou Pharmaceutical Company Information
  3. 6.1.2 Chongqing Yaoyou Pharmaceutical Business Overview
  4. 6.1.3 Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Product Portfolio
  6. 6.1.5 Chongqing Yaoyou Pharmaceutical Recent Developments
  7. 6.2 Jiuquan Dadeli pharmaceutical
  8. 6.2.1 Jiuquan Dadeli pharmaceutical Company Information
  9. 6.2.2 Jiuquan Dadeli pharmaceutical Business Overview
  10. 6.2.3 Jiuquan Dadeli pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiuquan Dadeli pharmaceutical Cobamamide Drugs Product Portfolio
  12. 6.2.5 Jiuquan Dadeli pharmaceutical Recent Developments
  13. 6.3 Jiangsu Jiuxu Pharmaceutical
  14. 6.3.1 Jiangsu Jiuxu Pharmaceutical Company Information
  15. 6.3.2 Jiangsu Jiuxu Pharmaceutical Business Overview
  16. 6.3.3 Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Product Portfolio
  18. 6.3.5 Jiangsu Jiuxu Pharmaceutical Recent Developments
  19. 6.4 North China Pharmaceutical Group
  20. 6.4.1 North China Pharmaceutical Group Company Information
  21. 6.4.2 North China Pharmaceutical Group Business Overview
  22. 6.4.3 North China Pharmaceutical Group Cobamamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 North China Pharmaceutical Group Cobamamide Drugs Product Portfolio
  24. 6.4.5 North China Pharmaceutical Group Recent Developments
  25. 6.5 Hebei Zhitong Biopharmaceutical
  26. 6.5.1 Hebei Zhitong Biopharmaceutical Company Information
  27. 6.5.2 Hebei Zhitong Biopharmaceutical Business Overview
  28. 6.5.3 Hebei Zhitong Biopharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hebei Zhitong Biopharmaceutical Cobamamide Drugs Product Portfolio
  30. 6.5.5 Hebei Zhitong Biopharmaceutical Recent Developments
  31. 6.6 Hainan Star Pharmaceutical
  32. 6.6.1 Hainan Star Pharmaceutical Company Information
  33. 6.6.2 Hainan Star Pharmaceutical Business Overview
  34. 6.6.3 Hainan Star Pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hainan Star Pharmaceutical Cobamamide Drugs Product Portfolio
  36. 6.6.5 Hainan Star Pharmaceutical Recent Developments
  37. 6.7 Haerbin Medisan
  38. 6.7.1 Haerbin Medisan Company Information
  39. 6.7.2 Haerbin Medisan Business Overview
  40. 6.7.3 Haerbin Medisan Cobamamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Haerbin Medisan Cobamamide Drugs Product Portfolio
  42. 6.7.5 Haerbin Medisan Recent Developments
  43. 6.8 Sinopharm Group Rongsheng Pharmaceutical
  44. 6.8.1 Sinopharm Group Rongsheng Pharmaceutical Company Information
  45. 6.8.2 Sinopharm Group Rongsheng Pharmaceutical Business Overview
  46. 6.8.3 Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Product Portfolio
  48. 6.8.5 Sinopharm Group Rongsheng Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Cobamamide Drugs Sales by Country
  2. 7.1.1 North America Cobamamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cobamamide Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Cobamamide Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cobamamide Drugs Market Size by Country
  6. 7.2.1 North America Cobamamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cobamamide Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Cobamamide Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cobamamide Drugs Sales by Country
  2. 8.1.1 Europe Cobamamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cobamamide Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Cobamamide Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cobamamide Drugs Market Size by Country
  6. 8.2.1 Europe Cobamamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cobamamide Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cobamamide Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cobamamide Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Cobamamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cobamamide Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cobamamide Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cobamamide Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Cobamamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cobamamide Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cobamamide Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cobamamide Drugs Sales by Country
  2. 10.1.1 South America Cobamamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cobamamide Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Cobamamide Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cobamamide Drugs Market Size by Country
  6. 10.2.1 South America Cobamamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cobamamide Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Cobamamide Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cobamamide Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Cobamamide Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cobamamide Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cobamamide Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cobamamide Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Cobamamide Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cobamamide Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cobamamide Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cobamamide Drugs Value Chain Analysis
  2. 12.1.1 Cobamamide Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cobamamide Drugs Production Mode & Process
  7. 12.2 Cobamamide Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cobamamide Drugs Distributors
  10. 12.2.3 Cobamamide Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst